Day: September 25, 2024

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 25, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation“) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, is pleased to announce that it has completed a non-brokered private placement with a single institutional investor pursuant to which the Corporation issued 4,000,000 common shares (the “Common Shares“) and an accompanying warrant exercisable for an aggregate of up to 2,000,000 Common Shares (each, a “Warrant Share”) at an exercise price of $5.00 (or approximately C$6.78) per Common Share (the...

IRVINE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that Aziz Mottiwala, Chief Commercial Officer, will participate in a virtual fireside chat at the UBS Virtual Ophthalmology Day 2024 taking place on Wednesday, October 2, at 6:00 a.m. PT / 9:00 a.m. ET. A live webcast and additional information about the presentation can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time. About Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients,...

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V:BNKR | OTCQB:BHLL) announces that it has closed the second tranche of the previously announced silver loan with Monetary Metals Bond III LLC (“MM”), an entity established by Monetary Metals & Co., in the principal amount of US$6,369,000, being the amount of US dollars equal to, as of September 24, 2024, 200,000 ounces of silver (the “Second Tranche”). As described in the news releases dated June 7, 2024, and August 8, 2024, MM has agreed to loan the Company a principal amount of US dollars equal to up to 1.2 million ounces of silver, to be advanced in one or more tranches, in support of the re-start and ongoing development of the Bunker Hill Mine (the “Silver Loan”). On August 8, 2024, the Company...

ANN ARBOR, Mich., Sept. 25, 2024 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that on September 23, 2024, the Company granted one new employee 3,500 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual’s entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. Each RSU will vest and become exercisable as to 25 percent of the shares on the one-year anniversary of the recipient’s vesting commencement date and will vest and become exercisable as to the remaining 75...

BEIJING, Sept. 25, 2024 (GLOBE NEWSWIRE) — ZW Data Action Technologies Inc. (Nasdaq: CNET) (“ZW Data” or the “Company”), an integrated online advertising, precision marketing, data analytics, and other value-added services company, announced today that its Board of Directors has approved a reverse stock split of its common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1-for-4 (the “Reverse Stock Split”). The Reverse Stock Split will take effect on September 30, 2024, and the shares of the Company will trade on a post-split basis on Nasdaq under the Company’s existing trading symbol “CNET,” at the market open on September 30, 2024, upon Nasdaq’s approval. The new CUSIP number following the Reverse Stock Split will be 98880R 307. Under Nevada Revised Statutes (“NRS”) Section 78.207, the Company may decrease...

PHILADELPHIA, Sept. 25, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced two presentations at the upcoming American College of Rheumatology (ACR) Convergence 2024, which is being held at the Walter E. Washington Convention Center in Washington, D.C. from November 14-19, 2024. The presentations will feature new and updated clinical data on CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy, which is being evaluated in multiple ongoing clinical trials in the RESET™ clinical development program. Details of the presentations are as follows: Oral Presentation: Title: Safety and Efficacy of CABA-201,...

Figure: 1Proforma StructureFigure: 2VivoPower and FASTUK remains attractive market for hydrogen companies with significant incentives introduced and announced by UK Government UK Government clean energy initiatives include establishing Great British Energy unit to be capitalised with US$11bn, augmented with the $9.7bn investment into National Wealth Fund Priority investment for both Great British Energy unit and National Wealth Fund is scaling up UK green hydrogen sector VivoPower has been headquartered in UK since 2016 Transaction subject to completion of number of conditions precedent, including closing of Tembo’s previously announced business combination and satisfactory completion of independent third-party opinion LONDON, Sept. 25, 2024 (GLOBE NEWSWIRE) — Nasdaq-listed VivoPower International Plc (“VivoPower”,...

HOUSTON, Sept. 25, 2024 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) plans to release its third quarter 2024 results on Wednesday, October 16, 2024, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, October 16, 2024, at 5:00 p.m. eastern time. A listen only live audio webcast of the conference call, along with any supplemental materials, can be accessed on the Crown Castle website at https://investor.crowncastle.com. Participants may join the conference call by dialing 833-816-1115 (Toll Free) or 412-317-0694 (International) at least 30 minutes prior to the start time. All dial-in participants should ask to join the Crown Castle call. A replay of the webcast will be available on the Investor page of Crown Castle’s website until...